Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reappraising the T category in hepatocellular carcinoma: Prognostic impact of the type and extent of vascular invasion.

Surgery·2026
Same author

Effects of empagliflozin alone and in combination with exercise on the soleus muscle in obese type 2 diabetic rats.

The journal of physiological sciences : JPS·2026
Same author

Log-transformed α-Fetoprotein and <i>Des</i>-γ-carboxy Prothrombin Predict Early Recurrence After Hepatectomy for Hepatocellular Carcinoma.

In vivo (Athens, Greece)·2026
Same author

Postoperative Abscesses in the Liver Resection Plane in Patients with a History of Biliary Tract Treatments: A Multicenter Cohort Study.

Asian Pacific journal of cancer prevention : APJCP·2026
Same author

Carbon Footprint in Hepatectomy Increases as the Approach Shifts From Open to Laparoscopic and Robot-Assisted Surgery.

Asian journal of endoscopic surgery·2026
Same author

Preoperative Serum Total Cholesterol Predicts Adjuvant Chemotherapy Completion After Pancreaticoduodenectomy for Pancreatic Cancer.

Anticancer research·2026

Related Experiment Video

Updated: Sep 13, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

4.6K

Interleukin-6 Secreted from Cancer-associated Fibroblast Inhibits Cancer Growth in Biliary Tract Cancer.

Naoki Tani1, Shimpei Eguchi1, Kenjiro Kimura1

  • 1Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Anticancer Research
|August 1, 2025
PubMed
Summary

Certain cancer-associated fibroblasts (CAFs) suppress tumor growth in biliary tract cancer (BTC) by releasing interleukin-6 (IL-6). This IL-6 signaling pathway improves patient survival outcomes.

Keywords:
Biliary tract cancercancer-associated fibroblastsinterleukin-6

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

244
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.8K

Related Experiment Videos

Last Updated: Sep 13, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

4.6K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

244
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.8K

Area of Science:

  • Oncology
  • Tumor Microenvironment Research
  • Cancer Biology

Background:

  • Cancer-associated fibroblasts (CAFs) play a dual role in the tumor microenvironment, potentially promoting or inhibiting tumor progression.
  • Understanding the specific functions of different CAF subsets is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To identify cancer-associated fibroblasts (CAFs) that inhibit proliferation in biliary tract cancer (BTC) cell lines.
  • To elucidate the underlying molecular mechanisms of this tumor-suppressive activity.

Main Methods:

  • Conditioned media from isolated BTC-derived CAFs were used to treat BTC and pancreatic cancer cell lines.
  • Cell proliferation, cytokine profiles, and the interleukin-6 (IL-6) signaling pathway (including SOCS3 and STAT3) were analyzed.
  • Immunohistochemistry and survival analyses were performed on BTC patient tissues.

Main Results:

  • A subset of CAFs demonstrated tumor-suppressive effects on BTC cell growth.
  • Interleukin-6 (IL-6) was identified as a key inhibitory cytokine secreted by these CAFs.
  • IL-6 treatment reduced BTC cell proliferation and modulated the SOCS3/STAT3 pathway. Stromal IL-6 expression correlated significantly with improved relapse-free and overall survival in BTC patients.

Conclusions:

  • Tumor-suppressive CAFs in BTC exert their function through IL-6 secretion.
  • The IL-6/SOCS3/STAT3 pathway mediates the inhibition of cancer cell proliferation.
  • Increased IL-6 and SOCS3 expression in the tumor stroma are associated with favorable clinical outcomes in BTC patients.